News Follow-Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center

2022/07/08

Li Zigang/Yin Feng's research group has made significant progress in the "group transfer" strategy based on matte salt molecules

Recently, the Li Zigang/Yin Feng research group of Pingshan Center published a research paper in the flagship journal of the Chinese Chemical Society, CCS Chemistry. In this paper, a group transfer strategy based on sulfonium salt molecules was developed for site selective modification of target protein Cysteine (Cys) through ligand directed chemistry.

2022/07/07

Aggregating Industry Potential, Executive Chairman of the International Symbiosis Strategic Industry Alliance Liu Danning Visits Pingshan Center

In order to implement the national strategy and aggregate the potential energy of the industry, Liu Danning, Executive Chairman of the International Symbiosis Strategic Industry Alliance (hereinafter referred to as "Symbiosis Alliance"), Chairman of Ningju Symbiosis (Shenzhen) Industrial Development Group Co., Ltd., Li Yongzhou, member of the CPPCC Luohu District and founder of China Science America City, and other delegations visited the Pingshan Biomedical R&D and Transformation Center of Shenzhen Bay Laboratory (hereinafter referred to as "Pingshan Center") on the morning of July 6, And conduct exchanges and discussions. Li Zigang, Executive Director of Pingshan Center, and platform leaders accompanied the visit and participated in the symposium.

2022/07/04

The Party Flag Flies at the Grassroots | Shenzhen Bay Laboratory Protects the Construction of Bright Science City with High Quality Party Building

In 2020, the Guangming Science City Party Building Joint Conference was established, becoming the first comprehensive party building platform among four comprehensive national science centers in China, attracting more than 30 key units to settle in. Among them, Shenzhen Bay Laboratory is promoting the dual integration of party building and scientific research through the close integration of party building, science, and talent, gathering strong confidence and determination to create the future.

2022/06/30

Scientific research trends | Li Zigang/Yin Feng's research group has made new research progress on Histidine proteome of breast cancer cells

Recently, the research team led by Li Zigang and Yin Feng from Pingshan Center/Peking University Shenzhen Graduate School published a research paper titled "Histidine Specific bioconjugation via visible light promoted proteomic activation" in the internationally renowned journal "Chemical Science", reporting a novel visible light catalyzed His chemical modification method and its chemical proteomics application.

2022/06/22

Six parties gather together, focusing on the development of traditional Chinese medicine industry in Pingshan

On June 20th, organized by the Management Committee of the Collaborative Innovation and Research Joint Laboratory of Traditional Chinese Medicine Digital Medicine, an exchange discussion was held at the Pingshan Biomedical Research and Transformation Center of the Shenzhen Bay Laboratory. The six parties had in-depth exchanges around the development of Pingshan Traditional Chinese Medicine and Innovative Medicine industries, exchanging opinions on the future cooperation direction and expectations, and reached a preliminary cooperation intention.

2022/06/22

"Branch co construction, scientific research integration and mutual promotion" - the second party branch of Shenzhen Bay Laboratory and the School of Pharmacy of Shenzhen Technology University held a party branch co construction exchange meeting

In order to strengthen political guidance and adhere to the integration of scientific research and party building, Zhao Weining, secretary of the Party branch of the School of Pharmacy of Shenzhen Technology University, and his delegation visited Pingshan Center on the morning of June 20.

2022/06/22

Huaxian Pharmaceutical Visits Pingshan Center of Shenzhen Bay Laboratory!

On the morning of June 17th, Wang Huifang, Vice President of the Market Operations Department of Huaxian Pharmaceutical and Secretary General of the District High Level Talent Association, Jian Feng, Director of the PMS Department of Huaxian Pharmaceutical, and Li Juncong, President of Lerui Pharmaceutical in the United States, visited the Pingshan Biopharmaceutical R&D and Transformation Center (hereinafter referred to as the "Pingshan Center") at the Shenzhen Bay Laboratory.

2022/06/10

β The therapeutic potential of amyloid protein surface inhibitors: only oligomers formed by secondary nucleation can disrupt the integrity of liposome membranes

On June 10th, the Li Zigang | Yin Feng research group at Pingshan Center and Professor John Viles from Queen Mary College London collaborated to publish an article in The FEBS Journal.

2022/06/10

The academic presentation at Pingshan Center has come to a successful conclusion!

On the morning of June 9th, the Pingshan Biopharmaceutical R&D and Transformation Center of Shenzhen Bay Laboratory and the Beipu Joint Research Center jointly held an academic presentation.